57
DTL Partner Advisory Committee & Topsector Life Sciences and Health Health~Holland Pro~Motion & In~Motion Prof. dr. Nico L.U. van Meeteren Executive Director www.health-holland.com @HealthHolland

Pro~Motion In~Motion€¦ · T-cell Factory Kite Mar 2015 M&A $21M uniQure BMS April 2015 Licensing $50m upfront, $50 near term, $254M milestones plus $217M for other targets AM-Pharma

  • Upload
    others

  • View
    0

  • Download
    0

Embed Size (px)

Citation preview

Page 1: Pro~Motion In~Motion€¦ · T-cell Factory Kite Mar 2015 M&A $21M uniQure BMS April 2015 Licensing $50m upfront, $50 near term, $254M milestones plus $217M for other targets AM-Pharma

DTL Partner Advisory Committee &

Topsector Life Sciences and Health Health~Holland

Pro~Motion & In~Motion

Prof. dr. Nico L.U. van Meeteren Executive Director

www.health-holland.com

@HealthHolland

Page 2: Pro~Motion In~Motion€¦ · T-cell Factory Kite Mar 2015 M&A $21M uniQure BMS April 2015 Licensing $50m upfront, $50 near term, $254M milestones plus $217M for other targets AM-Pharma

Life Sciences and health Success and change …

2005 Benedictus XVI

Franciscus 2013

Page 3: Pro~Motion In~Motion€¦ · T-cell Factory Kite Mar 2015 M&A $21M uniQure BMS April 2015 Licensing $50m upfront, $50 near term, $254M milestones plus $217M for other targets AM-Pharma

Alignment “If ‘I’ is replaced by ‘we’,

even illness turns into wellness”

Strategy building Pro~motion 2016-2019 … In~Motion 2016-2017 …

Page 4: Pro~Motion In~Motion€¦ · T-cell Factory Kite Mar 2015 M&A $21M uniQure BMS April 2015 Licensing $50m upfront, $50 near term, $254M milestones plus $217M for other targets AM-Pharma

Health~Holland Ambitions

Page 5: Pro~Motion In~Motion€¦ · T-cell Factory Kite Mar 2015 M&A $21M uniQure BMS April 2015 Licensing $50m upfront, $50 near term, $254M milestones plus $217M for other targets AM-Pharma

Programmatic Pillars

Page 6: Pro~Motion In~Motion€¦ · T-cell Factory Kite Mar 2015 M&A $21M uniQure BMS April 2015 Licensing $50m upfront, $50 near term, $254M milestones plus $217M for other targets AM-Pharma

Alignement Disciplines, experts and institutions …

Page 7: Pro~Motion In~Motion€¦ · T-cell Factory Kite Mar 2015 M&A $21M uniQure BMS April 2015 Licensing $50m upfront, $50 near term, $254M milestones plus $217M for other targets AM-Pharma

Alignment Scenario’s …

Page 8: Pro~Motion In~Motion€¦ · T-cell Factory Kite Mar 2015 M&A $21M uniQure BMS April 2015 Licensing $50m upfront, $50 near term, $254M milestones plus $217M for other targets AM-Pharma

Alignement Cross-‘inners’ and cross-overs …

•  Public Private Partnership: •  Ñational:

•  Inner: •  AMR, CARDIO, Onco XL, etc.

•  Over: •  Agrofood, Chemics, CLICK NL, Energy, ICT, Logistics •  Building blocks of life and IMDI •  European Open Science Cloud

•  International: •  China, East-Africa, USA

•  Communication •  News-updates, Portal, Twitter, etc.

•  Strategic Partnership •  Interdepartemental (EA, Health, SA, etc.)

Page 9: Pro~Motion In~Motion€¦ · T-cell Factory Kite Mar 2015 M&A $21M uniQure BMS April 2015 Licensing $50m upfront, $50 near term, $254M milestones plus $217M for other targets AM-Pharma

Programmatic Pillars

Page 10: Pro~Motion In~Motion€¦ · T-cell Factory Kite Mar 2015 M&A $21M uniQure BMS April 2015 Licensing $50m upfront, $50 near term, $254M milestones plus $217M for other targets AM-Pharma

Running

•  Enabling Technologies Call •  ZonMw, LSH, ALW

•  Data-Hub •  Diverse set of publuc and private (LSH) partners

•  FAIR Data Backbone •  DTL, ICT, LSH, Min. Health and EA, etc.

Page 11: Pro~Motion In~Motion€¦ · T-cell Factory Kite Mar 2015 M&A $21M uniQure BMS April 2015 Licensing $50m upfront, $50 near term, $254M milestones plus $217M for other targets AM-Pharma

Frontrunner

Page 12: Pro~Motion In~Motion€¦ · T-cell Factory Kite Mar 2015 M&A $21M uniQure BMS April 2015 Licensing $50m upfront, $50 near term, $254M milestones plus $217M for other targets AM-Pharma

Continuum of participation Reform of acute care (waiting list … empowerment period)

- 1959 -

Page 13: Pro~Motion In~Motion€¦ · T-cell Factory Kite Mar 2015 M&A $21M uniQure BMS April 2015 Licensing $50m upfront, $50 near term, $254M milestones plus $217M for other targets AM-Pharma

Strategy building Pro~motion 2016-2019 … In~Motion 2016-2017 …

Page 14: Pro~Motion In~Motion€¦ · T-cell Factory Kite Mar 2015 M&A $21M uniQure BMS April 2015 Licensing $50m upfront, $50 near term, $254M milestones plus $217M for other targets AM-Pharma

Topsector Policies and progress …

Page 15: Pro~Motion In~Motion€¦ · T-cell Factory Kite Mar 2015 M&A $21M uniQure BMS April 2015 Licensing $50m upfront, $50 near term, $254M milestones plus $217M for other targets AM-Pharma

LSH To do 2015-2016-2017 •  Sector:

-  Strategische en thematische Alignment -  PPPs

–  Onco XL, CARDIO, Bouwstenen van Leven, AMR, etc. -  Financieringsscenario’s (Health impact bonds)

–  TKI –  Involveren Charity fondsen/Social Investors/Family funds, Pensioenfondsen,

Zorgverzekeraars, Overheden (P → PP), etc. -  Internationaal

–  In- en export LSH Portfolio (EU en Push op prio’s [USA, China, Oost Afrika] en Pull) -  Communicatie

–  Portal, news-updates, etc.

•  Haags: -  Interdepartementale alignment (o.a. EZ-VWS: Health Deals)

Page 16: Pro~Motion In~Motion€¦ · T-cell Factory Kite Mar 2015 M&A $21M uniQure BMS April 2015 Licensing $50m upfront, $50 near term, $254M milestones plus $217M for other targets AM-Pharma

Building PPPs

•  H~H PPPs: •  Services, MedTech, (Bio)Pharma

•  Per pillar •  Between pillars (cross-‘inners’) •  Between sectors (cross-overs)

•  Agro-Food, Chemical, CLICKNL, HTSM. Logistics •  Enabling technology ICT: COMMIT2DATA

•  From Start up PPPs to Flagship PPPs

Page 17: Pro~Motion In~Motion€¦ · T-cell Factory Kite Mar 2015 M&A $21M uniQure BMS April 2015 Licensing $50m upfront, $50 near term, $254M milestones plus $217M for other targets AM-Pharma

PPPs AMR …

•  Opdracht: –  VWS (i.o.m. LSH)

•  Uitvoerder: –  Innotact (Projectleider: Maarten van Dongen; [email protected])

•  Proces en deliverable: –  Contourenplan o.b.v. consultaties (oplevering 1 december) ·  Speerpunten en contouren van programma ·  Voorstel Governance en betrokken stakeholders

–  Businessplan

•  Participatie LSH: –  Colja Laane (vanaf 1-11-’15 Nico van Meeteren)

Page 18: Pro~Motion In~Motion€¦ · T-cell Factory Kite Mar 2015 M&A $21M uniQure BMS April 2015 Licensing $50m upfront, $50 near term, $254M milestones plus $217M for other targets AM-Pharma
Page 19: Pro~Motion In~Motion€¦ · T-cell Factory Kite Mar 2015 M&A $21M uniQure BMS April 2015 Licensing $50m upfront, $50 near term, $254M milestones plus $217M for other targets AM-Pharma
Page 20: Pro~Motion In~Motion€¦ · T-cell Factory Kite Mar 2015 M&A $21M uniQure BMS April 2015 Licensing $50m upfront, $50 near term, $254M milestones plus $217M for other targets AM-Pharma

TKI LUMC …

•  TKI (k€) ·  Grondslag aangeleverd: Inzet-aanvragen toegekend:

-  2013: 0 118 -  2014: 0 0 -  2015: 0 246

-  Vb: Marieke Bax: Molecular diagnostics in patients with Rheumatoid Arthritis –  PPP 2015: 243 + 47

•  UMCX -  2014: 8.500 2.00

Page 21: Pro~Motion In~Motion€¦ · T-cell Factory Kite Mar 2015 M&A $21M uniQure BMS April 2015 Licensing $50m upfront, $50 near term, $254M milestones plus $217M for other targets AM-Pharma

IC 2016-2017 Zie: www.health-holland.com

•  Beheren

•  Beïnvloeden

•  Verrijken

Page 22: Pro~Motion In~Motion€¦ · T-cell Factory Kite Mar 2015 M&A $21M uniQure BMS April 2015 Licensing $50m upfront, $50 near term, $254M milestones plus $217M for other targets AM-Pharma
Page 23: Pro~Motion In~Motion€¦ · T-cell Factory Kite Mar 2015 M&A $21M uniQure BMS April 2015 Licensing $50m upfront, $50 near term, $254M milestones plus $217M for other targets AM-Pharma
Page 24: Pro~Motion In~Motion€¦ · T-cell Factory Kite Mar 2015 M&A $21M uniQure BMS April 2015 Licensing $50m upfront, $50 near term, $254M milestones plus $217M for other targets AM-Pharma

To do IMDI – LSH …

•  To do -  Samenwerking

-  CoRs –  Cross overs ·  HTSM

-  Financiering –  TKI ·  Proces en ‘targets’

–  MKB regelingen ·  MIT ·  Netwerkbijeenkomsten

-  Communicatie -  Positionering en profilering

Page 25: Pro~Motion In~Motion€¦ · T-cell Factory Kite Mar 2015 M&A $21M uniQure BMS April 2015 Licensing $50m upfront, $50 near term, $254M milestones plus $217M for other targets AM-Pharma

Systems development Rural and Urban Living Labs …

Page 26: Pro~Motion In~Motion€¦ · T-cell Factory Kite Mar 2015 M&A $21M uniQure BMS April 2015 Licensing $50m upfront, $50 near term, $254M milestones plus $217M for other targets AM-Pharma

Health~Holland, In~Motion Dutch Topsector Life Science and Health

http://www.health-holland.com/portal

Page 27: Pro~Motion In~Motion€¦ · T-cell Factory Kite Mar 2015 M&A $21M uniQure BMS April 2015 Licensing $50m upfront, $50 near term, $254M milestones plus $217M for other targets AM-Pharma

Success Biotech Partner Date Type Amount

ProFibrix Medicines Com. June 2013 M&A $90M upfront, $140M milestones

uniQure n.a. Jan 2014 IPO (Nasdaq) $92M

ArgenX n.a. Jul 2014 IPO (Euronext) $55M

Sapiens Medtronic Aug 2014 M&A $200M

Prosensa BioMarin Nov 2014 M&A $680M upfront, $160M milestones

ProQr n.a Sept 2014 IPO (Nasdaq) $97.5M

T-cell Factory Kite Mar 2015 M&A $21M

uniQure BMS April 2015 Licensing $50m upfront, $50 near term, $254M milestones plus $217M for other targets

AM-Pharma Pfizer May 2015 M&A $87.5M upfront, $512.5M milestones

Galapagos n.a. May 2015 PO (Nasdaq) $316,7M

Kiadis n.a. Jul 2015 IPO (Euronext) $37M

Merus n.a. Aug 2015 Series C financing $80.5M

Dezima Amgen Sept 2015 M&A $300M upfront, $1.25B milestones

Page 28: Pro~Motion In~Motion€¦ · T-cell Factory Kite Mar 2015 M&A $21M uniQure BMS April 2015 Licensing $50m upfront, $50 near term, $254M milestones plus $217M for other targets AM-Pharma

Success

Page 29: Pro~Motion In~Motion€¦ · T-cell Factory Kite Mar 2015 M&A $21M uniQure BMS April 2015 Licensing $50m upfront, $50 near term, $254M milestones plus $217M for other targets AM-Pharma

Success

Page 30: Pro~Motion In~Motion€¦ · T-cell Factory Kite Mar 2015 M&A $21M uniQure BMS April 2015 Licensing $50m upfront, $50 near term, $254M milestones plus $217M for other targets AM-Pharma

H~H claim

Page 31: Pro~Motion In~Motion€¦ · T-cell Factory Kite Mar 2015 M&A $21M uniQure BMS April 2015 Licensing $50m upfront, $50 near term, $254M milestones plus $217M for other targets AM-Pharma

Strategy building

Page 32: Pro~Motion In~Motion€¦ · T-cell Factory Kite Mar 2015 M&A $21M uniQure BMS April 2015 Licensing $50m upfront, $50 near term, $254M milestones plus $217M for other targets AM-Pharma

• Limitations • Safety • Innovative alternatives • Smart use of data • Time for change

Better off With … cooperations …

•  Breakthrough policy agreements •  Health Deals

•  Public Private Funding scenario’s •  Health Impact Bonds

Page 33: Pro~Motion In~Motion€¦ · T-cell Factory Kite Mar 2015 M&A $21M uniQure BMS April 2015 Licensing $50m upfront, $50 near term, $254M milestones plus $217M for other targets AM-Pharma

Future Think inside … continuate success …

“If ‘I’ is replaced by ‘we’, even illness turns into wellness”

Page 34: Pro~Motion In~Motion€¦ · T-cell Factory Kite Mar 2015 M&A $21M uniQure BMS April 2015 Licensing $50m upfront, $50 near term, $254M milestones plus $217M for other targets AM-Pharma

Functioneren

Page 35: Pro~Motion In~Motion€¦ · T-cell Factory Kite Mar 2015 M&A $21M uniQure BMS April 2015 Licensing $50m upfront, $50 near term, $254M milestones plus $217M for other targets AM-Pharma

Functioneren Life Span …

Func

tioni

ng

Time years of age

Major Life

Event

Page 36: Pro~Motion In~Motion€¦ · T-cell Factory Kite Mar 2015 M&A $21M uniQure BMS April 2015 Licensing $50m upfront, $50 near term, $254M milestones plus $217M for other targets AM-Pharma

Functioneren (H)Orde …

Page 37: Pro~Motion In~Motion€¦ · T-cell Factory Kite Mar 2015 M&A $21M uniQure BMS April 2015 Licensing $50m upfront, $50 near term, $254M milestones plus $217M for other targets AM-Pharma

Functioneren In health care … 0,0003% …

700.800 (80 x 8760)

200 (80 x 2,5)

Page 38: Pro~Motion In~Motion€¦ · T-cell Factory Kite Mar 2015 M&A $21M uniQure BMS April 2015 Licensing $50m upfront, $50 near term, $254M milestones plus $217M for other targets AM-Pharma

How

Page 39: Pro~Motion In~Motion€¦ · T-cell Factory Kite Mar 2015 M&A $21M uniQure BMS April 2015 Licensing $50m upfront, $50 near term, $254M milestones plus $217M for other targets AM-Pharma

Change Multi-facits strategie …

Page 40: Pro~Motion In~Motion€¦ · T-cell Factory Kite Mar 2015 M&A $21M uniQure BMS April 2015 Licensing $50m upfront, $50 near term, $254M milestones plus $217M for other targets AM-Pharma

PPP Multipurpose professional …

Page 41: Pro~Motion In~Motion€¦ · T-cell Factory Kite Mar 2015 M&A $21M uniQure BMS April 2015 Licensing $50m upfront, $50 near term, $254M milestones plus $217M for other targets AM-Pharma

Functioneren in health care Beter besef van en verbod op reductie van essenties …

Page 42: Pro~Motion In~Motion€¦ · T-cell Factory Kite Mar 2015 M&A $21M uniQure BMS April 2015 Licensing $50m upfront, $50 near term, $254M milestones plus $217M for other targets AM-Pharma

Self

Jameson and Longo, 2015; Collins and Varmus, 2015

€↑

Page 43: Pro~Motion In~Motion€¦ · T-cell Factory Kite Mar 2015 M&A $21M uniQure BMS April 2015 Licensing $50m upfront, $50 near term, $254M milestones plus $217M for other targets AM-Pharma

572

794 839

863 872 870 898

500

550

600

650

700

750

800

850

900

950

1000

2006 2007 2008 2009 2012 2013 2014

Continuum of success Reform …!

Paris, 2015

Page 44: Pro~Motion In~Motion€¦ · T-cell Factory Kite Mar 2015 M&A $21M uniQure BMS April 2015 Licensing $50m upfront, $50 near term, $254M milestones plus $217M for other targets AM-Pharma

Irish – Dutch Exchange Programme Proposedi*neraryofexchangeprogramme•  Monday22ndFebruary–Wednesday24thFebruary2016

•  Monday22ndFebruary

DepartDublin13:25ArriveAmsterdam16:00Recep<onforIrishdelega<on•  Tuesday23rdFebruary

VisitMaastrictUniversityHospital,RegionallivingLabs,Testbeds•  Wednesday24thFebruary

VisitPhillips,examplesofsuccessfulPublicPrivatePartnerships(PPP’s),briefingwithNicovanMeeterenDepartAmsterdam20:30ArriveDublin21:10

Page 45: Pro~Motion In~Motion€¦ · T-cell Factory Kite Mar 2015 M&A $21M uniQure BMS April 2015 Licensing $50m upfront, $50 near term, $254M milestones plus $217M for other targets AM-Pharma

Irish – Dutch Exchange Programme

•  Visiting Delegation Provide profiles of delegation members for receiving parties Responsible for own overseas travel arrangements

•  Receiving party Arranges collective meetings and fine-tunes programme Responsible for local transport When necessary will arrange or advise on lunches, dinners and hotel reservations.

Page 46: Pro~Motion In~Motion€¦ · T-cell Factory Kite Mar 2015 M&A $21M uniQure BMS April 2015 Licensing $50m upfront, $50 near term, $254M milestones plus $217M for other targets AM-Pharma

DICA

•  http://www.clinicalaudit.nl/jaarrapportage/2014/algemeen.html

Page 47: Pro~Motion In~Motion€¦ · T-cell Factory Kite Mar 2015 M&A $21M uniQure BMS April 2015 Licensing $50m upfront, $50 near term, $254M milestones plus $217M for other targets AM-Pharma

(Kennis) en Innovatiecontract 2016-2017

Health~Holland (Topsector Life Sciences and Health)

www.health-holland.com

Page 48: Pro~Motion In~Motion€¦ · T-cell Factory Kite Mar 2015 M&A $21M uniQure BMS April 2015 Licensing $50m upfront, $50 near term, $254M milestones plus $217M for other targets AM-Pharma

Van KIA naar (K)IC

•  Kennis en Innovatieagenda 2016-2019

•  Juni-augustus: Overleg stakeholders en partners LSH •  Min. EZ, OCW, VWS; NFU; NRPO;

Regio’s; SGF; TNO; ZonMw-NOW, etc. •  Augustus-september: IC drafts, checks en input TT, RG •  8 september: IC prefinal draft naar EZ t.b.v. Generiek IC •  September: IC finaliseren

•  Journalistieke bewerking •  Makeup en lay-out •  Correcties en aanvullingen

PDP, ZonMw-NWO, NWA, etc. •  5 oktober: Ondertekening Generiek IC bij Deltares •  6 oktober: IC H~H/LSH op website •  Oktober: KIA-IC glossy summary

•  (Kennis en) Innovatiecontract 2016-2017

Page 49: Pro~Motion In~Motion€¦ · T-cell Factory Kite Mar 2015 M&A $21M uniQure BMS April 2015 Licensing $50m upfront, $50 near term, $254M milestones plus $217M for other targets AM-Pharma

Van KIA naar (K)IC

•  (Kennis en) Innovatiecontract 2016-2017

•  Oplegger

•  Tabellen Indicatieve inzet 2016 en 2017

•  IC-tekst:

•  Hoofdlijnen en discussiepunten

•  Detailcommentaar naar Nico [email protected]

•  Proces •  dd. …

Page 50: Pro~Motion In~Motion€¦ · T-cell Factory Kite Mar 2015 M&A $21M uniQure BMS April 2015 Licensing $50m upfront, $50 near term, $254M milestones plus $217M for other targets AM-Pharma

To do •  TKI succes 2014, 2015, 2016

•  Charity fondsen/Social Investors/Family funds: -  Social Impact Finance BV:

-  Samuel Oudkerk -  Kabinetsopdracht “Divident naar maatschappelijke doelen”

-  Steven van Eijck, Guus Kramer en Paul Baan -  Vermogensfondsen

-  Rien van Gent

•  Pensioenfondsen:

•  Zorgverzekeraars:

Page 51: Pro~Motion In~Motion€¦ · T-cell Factory Kite Mar 2015 M&A $21M uniQure BMS April 2015 Licensing $50m upfront, $50 near term, $254M milestones plus $217M for other targets AM-Pharma

Praktijkonderzoek HBO •  Agenda Praktijkgericht Onderzoek Health

-  Stuurgroep: –  Edvard Beem, ZonMw –  Geri Bonhof (Vz), RG LSH –  Marieke Schuurmans, Chief Nursing Officer –  Richard Slotman, NRPO

-  Werkgroep –  Karin Alfenaar (Secr) + … [email protected]

•  Positieve dynamiek; kwaliteit, focus en massa; inhoudelijk gereed •  Werksessie 7 oktober

-  Bestuur, Directies, CoEs, Lectoraten -  Agenda: gezamenlijke programmering, regie en werkafspraken -  HCA: regie

–  To do: rapportage LSH TKI-pilot Hanzehogeschool

•  Publicatie Agenda (oktober) en presentatie RG (8 december)

Page 52: Pro~Motion In~Motion€¦ · T-cell Factory Kite Mar 2015 M&A $21M uniQure BMS April 2015 Licensing $50m upfront, $50 near term, $254M milestones plus $217M for other targets AM-Pharma

Continuation of success

Page 53: Pro~Motion In~Motion€¦ · T-cell Factory Kite Mar 2015 M&A $21M uniQure BMS April 2015 Licensing $50m upfront, $50 near term, $254M milestones plus $217M for other targets AM-Pharma

Change

Page 54: Pro~Motion In~Motion€¦ · T-cell Factory Kite Mar 2015 M&A $21M uniQure BMS April 2015 Licensing $50m upfront, $50 near term, $254M milestones plus $217M for other targets AM-Pharma

For the worse or the better

Page 55: Pro~Motion In~Motion€¦ · T-cell Factory Kite Mar 2015 M&A $21M uniQure BMS April 2015 Licensing $50m upfront, $50 near term, $254M milestones plus $217M for other targets AM-Pharma

Habemus

2005

2013

Page 56: Pro~Motion In~Motion€¦ · T-cell Factory Kite Mar 2015 M&A $21M uniQure BMS April 2015 Licensing $50m upfront, $50 near term, $254M milestones plus $217M for other targets AM-Pharma

School

Page 57: Pro~Motion In~Motion€¦ · T-cell Factory Kite Mar 2015 M&A $21M uniQure BMS April 2015 Licensing $50m upfront, $50 near term, $254M milestones plus $217M for other targets AM-Pharma